Davidson Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,871
| Closed | -$3.05M | – | 91 |
|
|
2024
Q4 | $3.05M | Buy |
5,871
+305
| +5% | +$159K | 0.8% | 41 |
|
|
2024
Q3 | $3.44M | Buy |
5,566
+295
| +6% | +$182K | 0.99% | 18 |
|
|
2024
Q2 | $2.91M | Buy |
5,271
+522
| +11% | +$289K | 0.9% | 44 |
|
|
2024
Q1 | $2.76M | Buy |
4,749
+15
| +0.3% | +$8.72K | 0.89% | 28 |
|
|
2023
Q4 | $2.51M | Buy |
4,734
+2,162
| +84% | +$1.15M | 0.91% | 25 |
|
|
2023
Q3 | $1.3M | Sell |
2,572
-6
| -0.2% | -$3.04K | 0.65% | 41 |
|
|
2023
Q2 | $1.35M | Buy |
2,578
+44
| +2% | +$23K | 0.67% | 47 |
|
|
2023
Q1 | $1.46M | Buy |
2,534
+143
| +6% | +$82.4K | 0.89% | 23 |
|
|
2022
Q4 | $1.32M | Sell |
2,391
-21
| -0.9% | -$11.6K | 0.9% | 19 |
|
|
2022
Q3 | $1.22M | Buy |
2,412
+102
| +4% | +$51.7K | 0.6% | 23 |
|
|
2022
Q2 | $1.26M | Hold |
2,310
| – | – | 0.59% | 18 |
|
|
2022
Q1 | $1.36M | Sell |
2,310
-192
| -8% | -$113K | 0.51% | 31 |
|
|
2021
Q4 | $1.67M | Buy |
2,502
+64
| +3% | +$42.7K | 0.91% | 14 |
|
|
2021
Q3 | $1.39M | Sell |
2,438
-252
| -9% | -$144K | 0.7% | 13 |
|
|
2021
Q2 | $1.36M | Buy |
2,690
+378
| +16% | +$191K | 0.65% | 21 |
|
|
2021
Q1 | $1.06M | Buy |
2,312
+400
| +21% | +$183K | 0.55% | 67 |
|
|
2020
Q4 | $891K | Buy |
1,912
+54
| +3% | +$25.2K | 0.5% | 44 |
|
|
2020
Q3 | $820K | Buy |
+1,858
| New | +$820K | 0.52% | 31 |
|